MedAccess

🆕 Today at UNGA, MedAccess became a signatory to an initiative between G7 development finance institutions (DFIs) - including British International Investment - the European Investment Bank (EIB), and IFC - International Finance Corporation to commit surge financing for medical countermeasures during future pandemics. The initiative aims to accelerate access to procurement, production and distribution of vaccines, therapeutics, diagnostics and other medical countermeasures. MedAccess will be part of efforts to ensure that financial resources and innovative finance tools are deployed quickly and effectively during the next pandemic, helping to bolster preparedness and response efforts by G7 nations. #UNGA | #UNGA79 Read more in our news story ⤵️ https://lnkd.in/e4iBaKC5

The November edition of our Access Matters newsletter is out 🗞️ This month's highlights include: 🔹 Our new Impact Case Studies, which look in more detail at what our agreements have achieved 🔹 Welcoming Dr Angela Gichaga to our Board 🔹 New film on the roll out of G6PD testing and P. vivax malaria treatment in Brazil Read it here ⬇

With this year's #WorldAIDSDay theme focused on rights, we are pleased to play a part by supporting three products which increases people's right to timely and effective testing: 1️⃣ An HIV self-test which enables people to test for HIV in privacy. 2️⃣ A dual test for HIV and syphilis that enables pregnant women to be tested for both conditions simultaneously. 3️⃣ Viral load testing to monitor whether patients are on effective HIV treatment. Learn more about the impact our market shaping guarantees are having on the #HIV response. https://lnkd.in/eYNa2rMb

🆕 Today we launch the first 🎬 in a new series focusing on the impact of our agreements. We've been working with Wondfo and the Clinton Health Access Initiative, Inc. since 2022 to bring more HIV self-tests to people who need them. Our volume guarantee enabled Wondfo to make their tests available at $1 each - a more affordable price for procurers. Through being able to purchase more tests, 482,000 people have now tested for HIV and 7,800 people have started treatment after receiving a diagnosis. Learn more about the public health and market challenges and how our agreement is contributing towards global HIV testing targets.

In September 2023, MedAccess became a founding member of the Impact Investing Initiative for Global Health. The initiative – known as Triple I for Global Health – aims to galvanise impact investors to target investments that promote equitable access to medicines and support global action on Universal Health Coverage (#UHC). From fighting lymphatic filariasis to controlling mosquitoes carrying malaria, see what the Initiative's members have achieved in its first Midterm Report ⤵️ https://lnkd.in/eQ9SKC3F

Ghana is taking three key steps to tackle its rising cases of antimicrobial resistance: 1️⃣ ensuring adherence to established guidelines for antibiotic use 2️⃣ improving antibiotic prescribing patterns in pre-and post-operative care 3️⃣ reducing surgical site infections through effective infection prevention and control measures. Read more from Gavi, the Vaccine Alliance's VaccinesWork blog about how the country is implementing these measure across its health system. https://lnkd.in/eS9ynSMk

🆕 Today we are launching our 2024 Impact Case Studies. The case studies go behind the headline impact to look at the public health and market challenges we sought to address and how we helped bring the benefits of remarkable scientific progress to more people more quickly. For example, since 2017, MedAccess-supported products have led to: 🔹 20,300 malaria relapses being averted due to G6PD tests enabling better malaria treatment 🔹 39,500 stillbirths being averted due to better access to dual HIV/syphilis tests 🔹 482,000 additional people testing for HIV because they had access to a self-test Read the impact case studies: https://lnkd.in/gBrz6Gn5

Less than half of the new antibiotics approved between 1999 and 2014 were registered in more than ten countries. And, only four of the 40 new antibiotics approved since 2000 are labelled for paediatric use. Infants in low- and middle-income countries routinely miss out on access to lifesaving antibiotics. Read more in Project Syndicate this #WAAW. ⤵️ https://lnkd.in/eFVW8YxF

Antimicrobial stewardship aims to optimise the use of antimicrobials in an effort to ensure that they remain effective for patients who need them. Takhona Hlatshwako, our recent Impact Intern discusses the importance of stewardship in this article. World #AntimicrobialAwarenessWeek | #WAAW https://lnkd.in/g4hipK9a

The 2024 Access to Medicine Index is here—a powerful tool for driving change in the pharmaceutical industry. By highlighting best practices, tracking progress, and pinpointing areas for urgent action, the Index shines a spotlight on what’s needed to improve access to medicine for underserved communities. It offers companies and stakeholders a transparent framework to assess, monitor, and enhance performance, while also shaping their public and investment profiles. https://lnkd.in/e5g_YHCm #AccessToMedicine | #HealthEquity | #EquitableAccess